|
SAV1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.327800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.165800E-02 |
| Normal-vs-Stage2 |
2.904800E-01 |
| Normal-vs-Stage3 |
2.990300E-02 |
| Normal-vs-Stage4 |
8.442100E-03 |
| Stage1-vs-Stage2 |
7.691600E-01 |
| Stage1-vs-Stage3 |
3.582400E-01 |
| Stage1-vs-Stage4 |
1.083620E-01 |
| Stage2-vs-Stage3 |
3.765400E-01 |
| Stage2-vs-Stage4 |
1.250030E-01 |
| Stage3-vs-Stage4 |
3.994800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.233900E-02 |
| Normal-vs-AfricanAmerican |
3.144800E-01 |
| Normal-vs-Asian |
1.258780E-01 |
| Caucasian-vs-AfricanAmerican |
6.914400E-01 |
| Caucasian-vs-Asian |
7.354600E-01 |
| AfricanAmerican-vs-Asian |
8.855800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.642080E-02 |
| Normal-vs-Female |
6.349800E-02 |
| Male-vs-Female |
3.032000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.518220E-01 |
| Normal-vs-Age(41-60Yrs) |
7.793600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.092170E-02 |
| Normal-vs-Age(81-100Yrs) |
9.916300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.143800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.258440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.938200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.964830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.006000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.155800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.110400E-01 |
| Classical-VS-Follicular |
9.096800E-01 |
| Classical-VS-Other |
4.885200E-01 |
| Classical-VS-Normal |
8.516100E-02 |
| Tall-VS-Follicular |
1.080450E-01 |
| Tall-VS-Other |
1.192590E-01 |
| Tall-VS-Normal |
1.147520E-02 |
| Follicular-VS-Other |
5.760600E-01 |
| Follicular-VS-Normal |
2.117200E-01 |
| Other-VS-Normal |
9.731000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.237600E-02 |
| Normal-vs-N1 |
2.852200E-02 |
| N0-vs-N1 |
4.311400E-01 |
|
|
